MHRA issues two updates on fluoroquinolone safety-Reference-Cited by-同舟云学术

MHRA issues two updates on fluoroquinolone safety

Published:2023-12-11 Issue:2 Volume:62 Page:19-19
ISSN:0012-6543
Container-title:Drug and Therapeutics Bulletin
language:en
Short-container-title:DTB

Author:

Abstract

AbstractOverview of:Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects. Drug Safety Update 2023;17:1. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: suicidal thoughts and behaviour. Drug Safety Update 2023;17:2.

Publisher

BMJ

Subject

Pharmacology (medical),General Medicine

Reference6 articles.

1. Medicines and Healthcare products Regulatory Agency . Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects. Drug Safety Update 2023;17:1.

2. Medicines and Healthcare products Regulatory Agency . Fluoroquinolone antibiotics: suicidal thoughts and behaviour. Drug Safety Update 2023;17:2.

3. Medicines and Healthcare products Regulatory Agency . Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. Drug Safety Update 2019;12:1.

4. Joint Formulary Committee . British National Formulary [online]. 2023. Available: https://bnf.nice.org.uk/ [Accessed 03 Nov 2023].

5. Bennett Institute for Applied Data Science, University of Oxford . OpenPrescribing [online]. 2023. Available: https://openprescribing.net/ [Accessed 03 Nov 2023].

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluoroquinolone antibiotics: Prescribe only as last resort, says UK regulator;BMJ;2024-01-24